+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Point-of-Care (POC) Testing, 2019-2023: Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • ID: 4703822
  • Report
  • 1007 pages
  • VPG Market Research
1 of 2

FEATURED COMPANIES

  • Abbott
  • Bio/Data
  • Decode Genetics
  • Fujirebio
  • Leica Biosystems
  • SDIX
  • MORE
This 1,007-page report provides comprehensive analysis of the emerging POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic instrument and reagent suppliers develop more effective business, R&D and marketing strategies.

Rationale
The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation Analysis
  • Review of the emerging POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.
  • Five-year test volume and reagent sales forecasts for chemistry, immunodiagnostic, microbiology, hematology and coagulation procedures by market segment:
  • Cancer Clinics
  • Ambulatory Care Centers
  • Surgery Centers
  • Nursing Homes
  • Birth Centers
and by test category:
  • Routine and Special Chemistry
  • Microbiology/Infectious Diseases
  • Hematology
  • Flow Cytometry
  • Coagulation
  • Immunoproteins
  • Drugs of Abuse
  • TDM
  • Endocrine Function
  • Tumor Markers
Sales and Market Share Analysis
  • Sales and market shares of major reagent and instrument suppliers.
Current and Emerging Products
  • Analysis of over 130 diagnostic procedures.
  • Review of the leading POC chemistry, immunoassay, hematology and coagulation analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices.
Technology Review
  • Emerging technologies and their applications for POC testing.
  • Comprehensive listings of companies developing or marketing POC diagnostic technologies and products, by test.
Competitive Assessments
  • Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.
Strategic Recommendations
  • Specific opportunities for new POC instruments and reagent systems with potentially significant market appeal during the next five years.
  • Design criteria for POC testing products.
  • Alternative business expansion strategies.
  • Potential market entry barriers and risks.
Methodology
This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and the authors proprietary data files.
Note: Product cover images may vary from those shown
2 of 2

Loading
LOADING...

3 of 2
  • Abbott
  • Accriva
  • Agilent Technologies
  • Axis-Shield
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Bio/Data
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Chrono-Log
  • Corgenix
  • Decode Genetics
  • Diagnostica Stago
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • EKF Diagnostics
  • Fujirebio
  • Grifols
  • Helena Laboratories
  • Hologic
  • Horiba
  • Instrumentation Laboratory/Werfen
  • Kyowa Medex
  • Leica Biosystems
  • Lonza
  • Nihon Kohden
  • Ortho-Clinical Diagnostics
  • Polymedco
  • Qiagen
  • Roche
  • SDIX
  • Sekisui Diagnostics
  • Sequenom
  • Siemens Healthineers
  • Sienco
  • Sysmex
  • Takara Bio
  • Thermo Fisher
  • Tosoh
  • Wako
Note: Product cover images may vary from those shown
Adroll
adroll